BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 18680715)

  • 1. The hepcidin-binding site on ferroportin is evolutionarily conserved.
    De Domenico I; Nemeth E; Nelson JM; Phillips JD; Ajioka RS; Kay MS; Kushner JP; Ganz T; Ward DM; Kaplan J
    Cell Metab; 2008 Aug; 8(2):146-56. PubMed ID: 18680715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the structure/activity relationships of the iron regulatory peptide hepcidin.
    Clark RJ; Tan CC; Preza GC; Nemeth E; Ganz T; Craik DJ
    Chem Biol; 2011 Mar; 18(3):336-43. PubMed ID: 21439478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular basis of iron overload disorders and iron-linked anemias.
    Kaplan J; Ward DM; De Domenico I
    Int J Hematol; 2011 Jan; 93(1):14-20. PubMed ID: 21210258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination.
    Qiao B; Sugianto P; Fung E; Del-Castillo-Rueda A; Moran-Jimenez MJ; Ganz T; Nemeth E
    Cell Metab; 2012 Jun; 15(6):918-24. PubMed ID: 22682227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study.
    Nemeth E; Preza GC; Jung CL; Kaplan J; Waring AJ; Ganz T
    Blood; 2006 Jan; 107(1):328-33. PubMed ID: 16141345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepcidin and ferroportin: the new players in iron metabolism.
    De Domenico I; Ward DM; Kaplan J
    Semin Liver Dis; 2011 Aug; 31(3):272-9. PubMed ID: 21901657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepcidin targets ferroportin for degradation in hepatocytes.
    Ramey G; Deschemin JC; Durel B; Canonne-Hergaux F; Nicolas G; Vaulont S
    Haematologica; 2010 Mar; 95(3):501-4. PubMed ID: 19773263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms.
    Billesbølle CB; Azumaya CM; Kretsch RC; Powers AS; Gonen S; Schneider S; Arvedson T; Dror RO; Cheng Y; Manglik A
    Nature; 2020 Oct; 586(7831):807-811. PubMed ID: 32814342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepcidin induces HIV-1 transcription inhibited by ferroportin.
    Xu M; Kashanchi F; Foster A; Rotimi J; Turner W; Gordeuk VR; Nekhai S
    Retrovirology; 2010 Dec; 7():104. PubMed ID: 21126372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.
    Nemeth E; Tuttle MS; Powelson J; Vaughn MB; Donovan A; Ward DM; Ganz T; Kaplan J
    Science; 2004 Dec; 306(5704):2090-3. PubMed ID: 15514116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of hepcidin and iron-overload disease.
    Lee PL; Beutler E
    Annu Rev Pathol; 2009; 4():489-515. PubMed ID: 19400694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient oxidative folding and site-specific labeling of human hepcidin to study its interaction with receptor ferroportin.
    Luo X; Jiang Q; Song G; Liu YL; Xu ZG; Guo ZY
    FEBS J; 2012 Sep; 279(17):3166-75. PubMed ID: 22776295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2.
    De Domenico I; Lo E; Ward DM; Kaplan J
    Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3800-5. PubMed ID: 19234114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis.
    Nemeth E; Ganz T
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport of hepcidin, an iron-regulatory peptide hormone, into retinal pigment epithelial cells via oligopeptide transporters and its relevance to iron homeostasis.
    Chothe PP; Gnana-Prakasam JP; Ananth S; Martin PM; Kannan R; Hinton DR; Smith SB; Ganapathy V
    Biochem Biophys Res Commun; 2011 Feb; 405(2):244-9. PubMed ID: 21219868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the biophysical and cell biological properties of ferroportin, a multipass integral membrane protein iron exporter.
    Rice AE; Mendez MJ; Hokanson CA; Rees DC; Björkman PJ
    J Mol Biol; 2009 Feb; 386(3):717-32. PubMed ID: 19150361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin.
    Kono S; Yoshida K; Tomosugi N; Terada T; Hamaya Y; Kanaoka S; Miyajima H
    Biochim Biophys Acta; 2010 Nov; 1802(11):968-75. PubMed ID: 20655381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload.
    Preza GC; Ruchala P; Pinon R; Ramos E; Qiao B; Peralta MA; Sharma S; Waring A; Ganz T; Nemeth E
    J Clin Invest; 2011 Dec; 121(12):4880-8. PubMed ID: 22045566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron-metabolic function and potential antibacterial role of Hepcidin and its correlated genes (Ferroportin 1 and Transferrin Receptor) in turbot (Scophthalmus maximus).
    Yang CG; Liu SS; Sun B; Wang XL; Wang N; Chen SL
    Fish Shellfish Immunol; 2013 Mar; 34(3):744-55. PubMed ID: 23274081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput screening of small molecules identifies hepcidin antagonists.
    Fung E; Sugianto P; Hsu J; Damoiseaux R; Ganz T; Nemeth E
    Mol Pharmacol; 2013 Mar; 83(3):681-90. PubMed ID: 23292796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.